Showing results (131-140 of 517) with videos related to
Sort By:
Pageof 52
Blood|July 19, 2011
Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myelomaRishi K Wadhera, Robert A Kyle, Dirk R Larson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 13, 2026
Diagnosis and Management of Multiple Myeloma With Central Nervous System InvolvementChristopher R D'Angelo, Benjamin A Derman, Srinivas Devarakonda, et al.Blood Cancer Journal|February 10, 2021
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)Li Pang, S Vincent Rajkumar, Prashant Kapoor, et al.Blood|July 25, 2025
Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain AmyloidosisPedro Vianna, Rajshekhar Chakraborty, Shahrier Hossain, et al.Blood|May 8, 2004
Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progressionShaji Kumar, Thomas E Witzig, Michael Timm, et al.American Journal of Hematology|December 30, 2025
Extramedullary Disease-Achilles Heel in Myeloma?Shaji Kumar, Joshua Richter, Saad Z Usmani, et al.Targeted Oncology|August 14, 2017
Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based AnalysesNeeraj Gupta, Huyuan Yang, Michael J Hanley, et al.The Journal of Applied Laboratory Medicine|May 26, 2023
Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined SignificanceKrasimira Rozenova, Maria Willrich, Melissa Snyder, et al.Blood Cancer Journal|July 30, 2020
In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myelomaAmit Kumar Mitra, Harish Kumar, Vijay Ramakrishnan, et al.Clinical Advances in Hematology & Oncology : H&O|October 7, 2022
Treatment of amyloid light chain cardiac amyloidosis: systematic review and future directionsDunya Alsomali, Dania Mohty, Martha Grogan, et al.Pageof 52